When Celebrities Prescribe — Regulating Drug Promotion on the Internet

Krüger N, Kong Y, Bachinger M, Kesselheim AS - New England Journal of Medicine

  • Regulation and Clinical Evidence

Summary:

Patient-targeted promotion of prescription drugs has expanded beyond traditional advertising to the Internet, with celebrities and influencers increasingly endorsing products such as GLP-1s, often evading regulatory scrutiny when promotion comes from social-media figures or telehealth companies rather than manufacturers directly. Stronger guardrails are needed, including updated FDA and FTC guidance on drug risk disclosure in advertising and expanded oversight of drug-class promotion.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
Talk bubble graphics representing commentary and opinion.

Politics and the Patient Encounter, in Dire Times

Avorn J - MedPage Today

  • Regulation and Clinical Evidence